德展健康: 第八届董事会第三十四次会议决议公告

Group 1 - The company held its 34th meeting of the 8th Board of Directors on August 26, 2025, with all 9 directors present, confirming compliance with legal and procedural requirements [1][2] - The board approved a proposal to amend the company's articles of association following the completion of a share repurchase plan, which involved the repurchase of 67,850,450 shares [1][2] - The board elected several candidates for the 9th Board of Directors, including Wei Zheming, Liu Wei, Gao Tao, Liu Xiaofeng, Fu Peng, and Zhan Haitan, with unanimous support from all directors [2][3] Group 2 - The board's proposal to hold the second extraordinary general meeting of shareholders on September 12, 2025, was approved, with a registration date set for September 5, 2025 [4] - The meeting will be conducted in a hybrid format, combining on-site and online voting, at a specified location in Urumqi, Xinjiang [4] - Relevant documents, including the resolutions from the board meeting and the nomination committee's records, will be made available for review [4][5]